| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |